FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 53 filers reported holding FENNEC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,000 | -27.3% | 1,310 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $11,000 | 0.0% | 1,310 | -28.8% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | -74.4% | 1,840 | -72.8% | 0.00% | -66.7% |
| Q4 2019 | $43,000 | +34.4% | 6,754 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $32,000 | +68.4% | 6,754 | +43.4% | 0.00% | +100.0% |
| Q2 2019 | $19,000 | -56.8% | 4,709 | -49.4% | 0.00% | -66.7% |
| Q1 2019 | $44,000 | -29.0% | 9,304 | -4.5% | 0.00% | -50.0% |
| Q4 2018 | $62,000 | -17.3% | 9,740 | +8.2% | 0.01% | 0.0% |
| Q3 2018 | $75,000 | – | 9,004 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 2,433,230 | $18,128,000 | 8.76% |
| Solas Capital Management, LLC | 800,000 | $5,960,000 | 4.55% |
| Southpoint Capital Advisors LP | 4,077,214 | $30,375,000 | 0.53% |
| 683 Capital Management, LLC | 1,110,000 | $8,269,000 | 0.39% |
| VALLEY FORGE INVESTMENT CONSULTANTS INC ADV | 40,000 | $298,000 | 0.26% |
| Avoro Capital Advisors LLC | 1,670,000 | $12,442,000 | 0.21% |
| Eventide Asset Management | 1,120,000 | $8,344,000 | 0.13% |
| Hartford Financial Management Inc. | 38,848 | $289,000 | 0.08% |
| Granahan Investment Management | 394,810 | $2,941,000 | 0.07% |
| Planned Solutions, Inc. | 800 | $6,000 | 0.01% |